This month, Katz Institute for Women’s Health interviewed Bonnie Litvack, MD, diagnostic radiologist at Northwell Health and JoAnn Pushkin, founder and executive director of DenseBreast-Info.org and ...

NISMAT is a pioneering hospital-based facility that’s solely dedicated to sports medicine. NISMAT has been at the forefront of advancing the field since our establishment in 1973 at Lenox Hill ...

We believe that athletes should have access to coordinated care to ensure their safety and well-being during practice and competition. Through our certified athletic trainer services, we provide ...

We offer renowned cardiac services and access to Northwell’s extensive network of resources, including research and clinical trials.

Treatment for pelvis fracture can take a variety of forms. The pelvis is the ring of bones at the base of the spine; it creates a basin-like structure that encloses many vital organs, including the ...

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial ...

As the largest health-based laboratory in the region, Northwell Health Labs provides a wide range of lab services from highly trained, compassionate experts. And we’re right where you need us in Rego ...

Prospective Survey Study of Bone Health and Adherence to Osteoporosis Management in Patients with Early Stage Breast Cancer on Adjuvant Endocrine Therapy with ...

A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) ...

NACHO-BIO: A Translational Biology Platform to Advance Understanding of Pathogenesis and Improve Outcomes for Patients with Histiocytic Disorders ...

This phase III trial compares the effects of nivolumab with chemo-immunotherapy versus chemo-immunotherapy alone in treating patients with newly diagnosed primary mediastinal B-cell lymphoma (PMBCL).

This randomized phase III trial investigates how well imatinib mesylate works in combination with two different chemotherapy regimens in treating patients with newly diagnosed Philadelphia chromosome ...